Bilgin Kadri Aribas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bilgin Kadri Aribas has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
Kemal Arda
From the Radiology Department (Yologlu, Aydin, Aribas, Arda), the Ear, Nose and Throat Surgery Department (Alp), Dr. Abdurrahman Yurtaslan Onkoloji Research Hospital, and the Radiology Department (Kizilgoz), Afyonkarahisar State Hospital, Ankara, Turkey
11 shared publicationsElif Aktas
Department of Radiology, Dr. A.Y. Ankara Oncology Education and Research Hospital, Mehmet Akif Ersoy Mah. 13. cad. No: 56. Yenimahalle, Ankara, Turkey
7 shared publications- Nazan Ciledag
Department of Radiology, Ankara Oncology Research and Education Hospital, Demetevler, Ankara 06460, Turkey
6 shared publications Burcu Sahin
3 shared publicationsEmrah Caglar
Department of Radiology, A.Y. Ankara Oncology Education and Research Hospital, Ankara, Turkey
3 shared publicationsG Sahin
3 shared publications
Latest Publications
- 9 August 2022
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (11) , 1735-1741
Tunneled Uncuffed Pigtail Drainage Catheter Placement in Patients with Refractory Ascites or Pleural Effusion: A Single-Center Experience
Purpose No evidence exists to support the use of tunneled non-cuffed pigtail drainage catheters in patients with refractory ascites or pleural effusion. The purpose of this study was to determine the feasibility of non-cuffed tunneled pigtail drainage catheters in patients with refractory ascites or pleural effusions. Materials and Methods Between October 5, 2020 and May 25, 2021, 34 pigtail catheters were implanted in 27 patients (17 males, 10 females; average age: 65.66 ± 12.04 years) under either ultrasound or computed-tomography guidance (19 catheters for ascites, 15 catheters for pleural effusion). Twenty-eight catheters (82.35%) were implanted for malignant etiologies, and 6 catheters (17.65%) were implanted for benign etiologies. The catheters (size: 8–14 French) were implanted through a subcutaneous tunnel. Complication rate and factors related to complications were analyzed. Catheter lifetime was analyzed with Kaplan–Meier method. Results Patency ranged from 3 to 211 days. None of the patients experienced a major complication (e.g., peritonitis and empyema). Meanwhile, 8 minor complications were observed including 3 catheter occlusion, 3 ascites leakage, 1 peri-catheter local skin infection, 1 peri-catheter local skin reaction. None of the etiologies were related to the catheter complications. However, the 8-F catheter was associated with a significantly higher complication rate (odds = 5.5, p = 0.044). The estimated mean [CI] dwelling time of a catheter was 59.18 [32.97, 85.39] days. Conclusions Image-guided insertion of tunneled peritoneal or pleural pigtail external drainage catheters achieved with a 100% technical success rate and resulted in an acceptable complication rate and catheter lifetime for the management of refractory ascites or pleural effusion.
- 9 August 2022
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (11) , 1735-1741
Tunneled Uncuffed Pigtail Drainage Catheter Placement in Patients with Refractory Ascites or Pleural Effusion: A Single-Center Experience
Purpose No evidence exists to support the use of tunneled non-cuffed pigtail drainage catheters in patients with refractory ascites or pleural effusion. The purpose of this study was to determine the feasibility of non-cuffed tunneled pigtail drainage catheters in patients with refractory ascites or pleural effusions. Materials and Methods Between October 5, 2020 and May 25, 2021, 34 pigtail catheters were implanted in 27 patients (17 males, 10 females; average age: 65.66 ± 12.04 years) under either ultrasound or computed-tomography guidance (19 catheters for ascites, 15 catheters for pleural effusion). Twenty-eight catheters (82.35%) were implanted for malignant etiologies, and 6 catheters (17.65%) were implanted for benign etiologies. The catheters (size: 8–14 French) were implanted through a subcutaneous tunnel. Complication rate and factors related to complications were analyzed. Catheter lifetime was analyzed with Kaplan–Meier method. Results Patency ranged from 3 to 211 days. None of the patients experienced a major complication (e.g., peritonitis and empyema). Meanwhile, 8 minor complications were observed including 3 catheter occlusion, 3 ascites leakage, 1 peri-catheter local skin infection, 1 peri-catheter local skin reaction. None of the etiologies were related to the catheter complications. However, the 8-F catheter was associated with a significantly higher complication rate (odds = 5.5, p = 0.044). The estimated mean [CI] dwelling time of a catheter was 59.18 [32.97, 85.39] days. Conclusions Image-guided insertion of tunneled peritoneal or pleural pigtail external drainage catheters achieved with a 100% technical success rate and resulted in an acceptable complication rate and catheter lifetime for the management of refractory ascites or pleural effusion.
- 28 April 2022
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 6 (1) , 38-47
COVID-19: CO-RADS Kategorik Değerlendirme Sistemi ile Toraks Bilgisayarlı Tomografi Görüntülemenin Tanısal Değerinin Araştırılması
Amaç: ‘Severe Acute Respiratory Syndrome Corona Virus 2 (SARS CoV-2)’ nin etken olduğu COVID-19 hastalığının kesin tanısı reverse transcriptase-polymerase chain reaction (RT-PCR) testi ile mümkündür. Toraks bilgisayarlı tomografisi (BT) tarama yöntemi olmamakla beraber hızlı filyasyon ve tedavi için yaygın kullanılmıştır. Bu çalışmada salgının ilk pikinde BT’nin COVID-19 için tanısal değeri araştırılmıştır. Gereç ve Yöntemler: 16 Mart-30 Nisan 2020 arasında COVID-19 şüphesi ile Radyoloji kliniğinde toraks BT yapılmış ardışık tüm yetişkin hastalar retrospektif tarandı. Görüntüler COVID-19 Reporting and Data System (CO-RADS)’e göre COVID-19 şüphe olasılığı bakımından değerlendirildi. Akciğerdeki tutulum bulguları ile hastaların yaş, cinsiyet ve komorbid hastalıkları kaydedildi. Bulgular: Yaş ortalama ± SD, 53.3±19.4; 262’si (%52) erkek ve 242’si (%48) kadın, toplam 504 olgu dahil edildi. 103 (%20.4) hastada RT-PCR pozitifliği vardı. CO-RADS 1 olguların 29/291 (%9.96)’i; CO-RADS 2’nin 4/65 (%26)’ü; CO-RADS 3’ün 15/63 (%23.8)’ü; CO-RADS 4’ün 19/28 (%67.9)’ünde; CO-RADS 5’in 36/57 (%63.2)’inde RT-PCR pozitifliği saptanmıştır. 356 hasta CO-RADS (1-3); 85 hasta CO-RADS (4.5)’ti. Duyarlılık, özgüllük, pozitif ve negatif olabilirlik oranları, prevalans, pozitif ve negatif prediktif değerler ve doğruluk oranları sırasıyla; %53.4, %92.52, 7.14, 0.5, %20.44, %64.71, %88.54 ve %84.52 saptandı. Sonuç: CO-RADS kategorizasyonu, COVID-19 pnömonisinde tanı değerini arttırmaktadır. Toraks BT’nin COVID-19 için özgüllüğü, pozitif ve negatif prediktif değeri yüksek ancak duyarlılığı düşüktür. Bilgisayarlı tomografinin tanısal veya tarama amaçlı kullanılaması uygun değildir.
- 28 April 2022
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 6 (1) , 38-47
COVID-19: CO-RADS Kategorik Değerlendirme Sistemi ile Toraks Bilgisayarlı Tomografi Görüntülemenin Tanısal Değerinin Araştırılması
Amaç: ‘Severe Acute Respiratory Syndrome Corona Virus 2 (SARS CoV-2)’ nin etken olduğu COVID-19 hastalığının kesin tanısı reverse transcriptase-polymerase chain reaction (RT-PCR) testi ile mümkündür. Toraks bilgisayarlı tomografisi (BT) tarama yöntemi olmamakla beraber hızlı filyasyon ve tedavi için yaygın kullanılmıştır. Bu çalışmada salgının ilk pikinde BT’nin COVID-19 için tanısal değeri araştırılmıştır. Gereç ve Yöntemler: 16 Mart-30 Nisan 2020 arasında COVID-19 şüphesi ile Radyoloji kliniğinde toraks BT yapılmış ardışık tüm yetişkin hastalar retrospektif tarandı. Görüntüler COVID-19 Reporting and Data System (CO-RADS)’e göre COVID-19 şüphe olasılığı bakımından değerlendirildi. Akciğerdeki tutulum bulguları ile hastaların yaş, cinsiyet ve komorbid hastalıkları kaydedildi. Bulgular: Yaş ortalama ± SD, 53.3±19.4; 262’si (%52) erkek ve 242’si (%48) kadın, toplam 504 olgu dahil edildi. 103 (%20.4) hastada RT-PCR pozitifliği vardı. CO-RADS 1 olguların 29/291 (%9.96)’i; CO-RADS 2’nin 4/65 (%26)’ü; CO-RADS 3’ün 15/63 (%23.8)’ü; CO-RADS 4’ün 19/28 (%67.9)’ünde; CO-RADS 5’in 36/57 (%63.2)’inde RT-PCR pozitifliği saptanmıştır. 356 hasta CO-RADS (1-3); 85 hasta CO-RADS (4.5)’ti. Duyarlılık, özgüllük, pozitif ve negatif olabilirlik oranları, prevalans, pozitif ve negatif prediktif değerler ve doğruluk oranları sırasıyla; %53.4, %92.52, 7.14, 0.5, %20.44, %64.71, %88.54 ve %84.52 saptandı. Sonuç: CO-RADS kategorizasyonu, COVID-19 pnömonisinde tanı değerini arttırmaktadır. Toraks BT’nin COVID-19 için özgüllüğü, pozitif ve negatif prediktif değeri yüksek ancak duyarlılığı düşüktür. Bilgisayarlı tomografinin tanısal veya tarama amaçlı kullanılaması uygun değildir.
- 19 November 2021
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 24 (5) , 933-941
The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma
Catheter-related complications are observed in infusion of chemotherapy, and these were encountered with targeted therapies. Our principle is to study non-mechanical effects of type and initiation time of chemotherapy among the other factors on patency of totally implantable vascular access devices (TIVAD) inserted in patients with colorectal carcinoma. This is a one-center retrospective cohort study. We analyzed TIVAD related complications in 624 patients with colorectal carcinoma. The patients were categorized by chemotherapy type (non-target-directed chemotherapy agents (Group A), bevacizumab (Group B), and cetuximab (Group C)). Additionally, we divided the patients into groups by the time interval between TIVAD insertion and chemotherapy initiation. According to our study, a 3-day period was optimal. Therefore, we named the groups as within 3 days and beyond 3 days, and called this process 3 days cut-off. Age, gender, jugular-subclavian access, platelet count, INR, the types of chemotherapy, and the initiation time of chemotherapy were investigated by survival tests. We compared chemotherapy type groups both one-by-one and combined into one group. The TIVADs were removed due to the complications in 11 patients of Group A, 6 patients of Group B, and 3 patients of Group C. Only chemotherapy type was significant (p = 0.011) in Cox regression test. A clear difference (p = 0.010) was detected between the catheter patency of Group A and combination of Groups B and C, because of skin necrosis and thrombosis. Within 3 days of their first chemotherapy day, an important difference between Group A and Group C (p = 0.013) was observed in the TIVAD patency. The same observation was made between Group A and Group B (p = 0.007). Beyond this period, no major difference was detected (p = 0.341). A major effect on catheter patency was detected by using the target-directed chemotherapy agent within 3 days, which should be considered in target-directed chemotherapy.
- 19 November 2021
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 24 (5) , 933-941
The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma
Catheter-related complications are observed in infusion of chemotherapy, and these were encountered with targeted therapies. Our principle is to study non-mechanical effects of type and initiation time of chemotherapy among the other factors on patency of totally implantable vascular access devices (TIVAD) inserted in patients with colorectal carcinoma. This is a one-center retrospective cohort study. We analyzed TIVAD related complications in 624 patients with colorectal carcinoma. The patients were categorized by chemotherapy type (non-target-directed chemotherapy agents (Group A), bevacizumab (Group B), and cetuximab (Group C)). Additionally, we divided the patients into groups by the time interval between TIVAD insertion and chemotherapy initiation. According to our study, a 3-day period was optimal. Therefore, we named the groups as within 3 days and beyond 3 days, and called this process 3 days cut-off. Age, gender, jugular-subclavian access, platelet count, INR, the types of chemotherapy, and the initiation time of chemotherapy were investigated by survival tests. We compared chemotherapy type groups both one-by-one and combined into one group. The TIVADs were removed due to the complications in 11 patients of Group A, 6 patients of Group B, and 3 patients of Group C. Only chemotherapy type was significant (p = 0.011) in Cox regression test. A clear difference (p = 0.010) was detected between the catheter patency of Group A and combination of Groups B and C, because of skin necrosis and thrombosis. Within 3 days of their first chemotherapy day, an important difference between Group A and Group C (p = 0.013) was observed in the TIVAD patency. The same observation was made between Group A and Group B (p = 0.007). Beyond this period, no major difference was detected (p = 0.341). A major effect on catheter patency was detected by using the target-directed chemotherapy agent within 3 days, which should be considered in target-directed chemotherapy.
- Open Access
- 3 April 2021
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 5 (1) , 101-105
Postoperative Developing Bronchopleural Fistula in a Patient Having A Predisposing Aspergillus: Radiological Evaluation
Bronkoplevral fistül (BPF), torasik cerrahi sonrası gelişebilecek en kötü komplikasyonlardan biridir. Bildirilen sıklığı %0.8-15’tir ve mortalite oranı %30-70 olup çoğunlukla sağ pnömonektomiden sonra görülür. Preoperatif kontrol edilemeyen plevropulmoner enfeksiyon, travma ve preoperatif radyoterapi uygulanması predispozan faktörlerdir. BPF’deki bilgisayarlı tomografi (BT) bulguları plevral alandaki hava-sıvı koleksiyonunu içerir ve hava yolundan veya akciğer parankiminden plevral alana olan fistül yolu veya ilişkiyi gösterir. Bu olguda predispozan olarak sağ akciğerde tedaviye yanıt vermeyen aspergillus nedeniyle sağ lobektomi uygulanan ve operasyon sonrasında bronkoplevral fistül gelişen 65 yaşındaki kadın hastanın klinik ve radyolojik bulgularını sunuyoruz. Pnömonektomi veya lobektomi sonrasında diğer komplikasyonların değerlendirilmesi için klinik yakın takip önemlidir. Takipler sırasında radyolojik akut değişiklikler klinik olarak az öneme sahip olsalar bile diğer büyük problemlerin önemli habercisidir. Radyolojik takipler sırasında ufak değişiklikleri kapsamada girişimsel olmayan bilgisayarlı tomografi ilk tercih olmalıdır.
- 3 April 2021
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 5 (1) , 101-105
Open AccessPostoperative Developing Bronchopleural Fistula in a Patient Having A Predisposing Aspergillus: Radiological Evaluation
Bronkoplevral fistül (BPF), torasik cerrahi sonrası gelişebilecek en kötü komplikasyonlardan biridir. Bildirilen sıklığı %0.8-15’tir ve mortalite oranı %30-70 olup çoğunlukla sağ pnömonektomiden sonra görülür. Preoperatif kontrol edilemeyen plevropulmoner enfeksiyon, travma ve preoperatif radyoterapi uygulanması predispozan faktörlerdir. BPF’deki bilgisayarlı tomografi (BT) bulguları plevral alandaki hava-sıvı koleksiyonunu içerir ve hava yolundan veya akciğer parankiminden plevral alana olan fistül yolu veya ilişkiyi gösterir. Bu olguda predispozan olarak sağ akciğerde tedaviye yanıt vermeyen aspergillus nedeniyle sağ lobektomi uygulanan ve operasyon sonrasında bronkoplevral fistül gelişen 65 yaşındaki kadın hastanın klinik ve radyolojik bulgularını sunuyoruz. Pnömonektomi veya lobektomi sonrasında diğer komplikasyonların değerlendirilmesi için klinik yakın takip önemlidir. Takipler sırasında radyolojik akut değişiklikler klinik olarak az öneme sahip olsalar bile diğer büyük problemlerin önemli habercisidir. Radyolojik takipler sırasında ufak değişiklikleri kapsamada girişimsel olmayan bilgisayarlı tomografi ilk tercih olmalıdır.
- 8 February 2021
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 16 (1) , 12-18
THE USE OF DOPPLER PERFUSION INDEX IN THE DETECTION OF COLORECTAL CANCER HEPATIC METASTASES
Amaç Kolon kanseri gastrointestinal sistemin en sık görülen kanseri olup önemli bir morbidite ve mortalite sebebidir. En sık yayılım gösterdiği organ karaciğerdir. Hastalığın tanısı anında karaciğerde metastaz varlığı azımsanamayacak derecededir. Takip sürecinde de ayrıca karaciğer metastazları gelişmektedir. Kolon kanserinin karaciğer metastazlarının erken tanısı önemlidir. Erken tanıda karaciğer perfüzyon değişikliklerinin kullanılabileceği ötedenberi çalışma konusu olmuştur. Hepatik arteryel kan akımında artış yada portal venöz kan akımında azalma ile ortaya çıkan ve hepatik arteryel kan akımının total karaciğer kan akımına oranını ifade eden Doppler Perfüzyon İndeksi olarak tanımlanmış bir kavram bulunmaktadır. Biz de karaciğerde görünür metastazı bulunmayan kolon kanserli hastalarda DPİ ile mikrometastaz varlığını tesbit etmeyi amaçladık. Gereç ve yöntemler Kolon kanseri tanılı ve karaciğerinde görünür metastazı bulunmayan 79 hastanın DPİ ölçümlerini yapıp prospektif olarak görünür metastaz gelişimi yönünden takip ettik. Bulgular Takibimiz esnasında 2 hastada exitus ve 9 hastada görünür metastaz gelişmiş olup hasta grubumuzda elde ettiğimiz DPİ değerleri metastaz varlığını erken tesbit etmede literatürle uyumlu olarak değerlendirilmiştir. Sonuç Ucuz, noninvazif ve doğrudan ölçüm yapılabilen dupleks RDUS yöntemiyle, kolorektal kanserli hastaların hepatik metastazlarının erken aşamada tesbit edilebileceğini düşünüyoruz.
- 8 February 2021
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 16 (1) , 12-18
THE USE OF DOPPLER PERFUSION INDEX IN THE DETECTION OF COLORECTAL CANCER HEPATIC METASTASES
Amaç Kolon kanseri gastrointestinal sistemin en sık görülen kanseri olup önemli bir morbidite ve mortalite sebebidir. En sık yayılım gösterdiği organ karaciğerdir. Hastalığın tanısı anında karaciğerde metastaz varlığı azımsanamayacak derecededir. Takip sürecinde de ayrıca karaciğer metastazları gelişmektedir. Kolon kanserinin karaciğer metastazlarının erken tanısı önemlidir. Erken tanıda karaciğer perfüzyon değişikliklerinin kullanılabileceği ötedenberi çalışma konusu olmuştur. Hepatik arteryel kan akımında artış yada portal venöz kan akımında azalma ile ortaya çıkan ve hepatik arteryel kan akımının total karaciğer kan akımına oranını ifade eden Doppler Perfüzyon İndeksi olarak tanımlanmış bir kavram bulunmaktadır. Biz de karaciğerde görünür metastazı bulunmayan kolon kanserli hastalarda DPİ ile mikrometastaz varlığını tesbit etmeyi amaçladık. Gereç ve yöntemler Kolon kanseri tanılı ve karaciğerinde görünür metastazı bulunmayan 79 hastanın DPİ ölçümlerini yapıp prospektif olarak görünür metastaz gelişimi yönünden takip ettik. Bulgular Takibimiz esnasında 2 hastada exitus ve 9 hastada görünür metastaz gelişmiş olup hasta grubumuzda elde ettiğimiz DPİ değerleri metastaz varlığını erken tesbit etmede literatürle uyumlu olarak değerlendirilmiştir. Sonuç Ucuz, noninvazif ve doğrudan ölçüm yapılabilen dupleks RDUS yöntemiyle, kolorektal kanserli hastaların hepatik metastazlarının erken aşamada tesbit edilebileceğini düşünüyoruz.
- Open Access
- 1 March 2018
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 49 (1) , 281-283
Unusual presentation of tubular breast carcinoma as non-mass enhancement
- 1 March 2018
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 49 (1) , 281-283
Open AccessUnusual presentation of tubular breast carcinoma as non-mass enhancement
- 12 January 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1084) , 20170705
Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
Objective: MRI is being used increasingly as a modality that can provide important information about breast cancer. Diffusion-weighted imaging (DWI) is an imaging technique from which apparent diffusion coefficient (ADC) values can be calculated in addition to obtaining important structural information which cannot be obtained from other imaging studies. We did not find any significant relationships between ADC values and prognostic factors, but did provide some explanations for conflicting results in the literature. Methods: The ADC results of 61 females with invasive ductal carcinomas were evaluated. DWI was performed and ADC values were calculated from the area in which restriction of diffusion was the highest in ADC mapping. B value was 500 and region of interest (ROI) was designated between 49 and 100 mm2. Calculations were performed automatically by the device. Tissue samples were obtained for prognostic factor evaluation. The relationships between ADC and prognostic factors were investigated. Comparisons between groups were made with one-way ANOVA and Kruskal Wallis test. Pairwise comparisons were made with Dunn’s test. Analyses of categorical variables were made with Chi-square test. Results: We found a weak negative correlation between ADC and Ki-67 values (r = −0.279; p = 0.029). When we compared ADC values in regard to tumour type, we found no significant differences for tumour grade, Ki-67 positivity, estrogen receptor positivity, progesterone receptor positivity, C-erb B2, lymphovascular invasion and ductal carcinoma in situ or lobular carcinoma in situ component. On a side note, we found that mean ADC values decreased as tumour grade increased; however, this was not statistically significant. Conclusion: The literature contains studies that report conflicting results which may be caused by differences in B values, ROI area and magnetic field strength. Multicentre studies and systematic reviews of these findings may produce crucial data for the use of DWI in breast cancer. Advances in knowledge: To determine if any significant relationship exists between DWI findings and prognostic factors of breast cancer.
- 12 January 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1084) , 20170705
Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
Objective: MRI is being used increasingly as a modality that can provide important information about breast cancer. Diffusion-weighted imaging (DWI) is an imaging technique from which apparent diffusion coefficient (ADC) values can be calculated in addition to obtaining important structural information which cannot be obtained from other imaging studies. We did not find any significant relationships between ADC values and prognostic factors, but did provide some explanations for conflicting results in the literature. Methods: The ADC results of 61 females with invasive ductal carcinomas were evaluated. DWI was performed and ADC values were calculated from the area in which restriction of diffusion was the highest in ADC mapping. B value was 500 and region of interest (ROI) was designated between 49 and 100 mm2. Calculations were performed automatically by the device. Tissue samples were obtained for prognostic factor evaluation. The relationships between ADC and prognostic factors were investigated. Comparisons between groups were made with one-way ANOVA and Kruskal Wallis test. Pairwise comparisons were made with Dunn’s test. Analyses of categorical variables were made with Chi-square test. Results: We found a weak negative correlation between ADC and Ki-67 values (r = −0.279; p = 0.029). When we compared ADC values in regard to tumour type, we found no significant differences for tumour grade, Ki-67 positivity, estrogen receptor positivity, progesterone receptor positivity, C-erb B2, lymphovascular invasion and ductal carcinoma in situ or lobular carcinoma in situ component. On a side note, we found that mean ADC values decreased as tumour grade increased; however, this was not statistically significant. Conclusion: The literature contains studies that report conflicting results which may be caused by differences in B values, ROI area and magnetic field strength. Multicentre studies and systematic reviews of these findings may produce crucial data for the use of DWI in breast cancer. Advances in knowledge: To determine if any significant relationship exists between DWI findings and prognostic factors of breast cancer.
- Open Access
- 1 December 2016
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 37 (12) , 1412-1416
Diffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results
Diffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results
- 1 December 2016
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 37 (12) , 1412-1416
Open AccessDiffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results
Diffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results
- Open Access
- 12 November 2016
- Published by Brieflands in Iranian Journal of Radiology
- Vol. In press (In press)
Factors on Patency Periods of Subcutaneous Central Venous Port: Long-Term Results of 1,408 Patients
Background: Studies have reported factors affecting the efficacy of subcutaneous venous chest port catheters placed into jugular or subclavian veins using a radiological technique. There is ongoing debate for this efficacy in these series. Objectives: To examine factors on patency times, including complications of subcutaneous venous chest port insertions, using ultrasonography guidance in 1,408 patients over a long-term follow-up. Patients and Methods: Between April 2009 and March 2014, subcutaneous venous chest ports were placed in 1,408 patients, 574 women and 834 men (mean age, 55.4 ± 12.1 years). Factors affecting the port patency were examined. Age, gender, access, malignancy site, and coagulation parameters were variables. A multivariable Cox regression test was used. Additionally, the successes were compared by univariate Kaplan-Meier survival analysis. Results: Fifty-seven patients underwent port removal because of complications. Complication due to catheter patency time, as number of specific complication per 100 catheter days divided by total patency days shown in parenthesis. Ports were explanted in 29 patients because of thrombosis (0.0054), in nine patients because of infection (0.0017), in eight patients because of catheter malposition (0.0015), in five patients because of bleeding (0.0009), in five patients because of skin necrosis with infection (0.0009) and one patient because of a port reservoir flip-over (0.0002), of a total of 57 patients (0.0107). The patency was similar in the two central veins (P = 0.230). No factor was significant except for the malignancy site (P = 0.002). The malignancy site and gender were significant factors for thrombosis. Port removal was significantly higher in extremities involving two regions and in female patients. Conclusions: Patency was not different between two venous access groups. The malignancy site was the only significant factor for success. Keywords: Central Venous Port; Interventional Radiology; Cancer; Thrombosis; Catheter
- 12 November 2016
- Published by Brieflands in Iranian Journal of Radiology
- Vol. In press (In press)
Open AccessFactors on Patency Periods of Subcutaneous Central Venous Port: Long-Term Results of 1,408 Patients
Background: Studies have reported factors affecting the efficacy of subcutaneous venous chest port catheters placed into jugular or subclavian veins using a radiological technique. There is ongoing debate for this efficacy in these series. Objectives: To examine factors on patency times, including complications of subcutaneous venous chest port insertions, using ultrasonography guidance in 1,408 patients over a long-term follow-up. Patients and Methods: Between April 2009 and March 2014, subcutaneous venous chest ports were placed in 1,408 patients, 574 women and 834 men (mean age, 55.4 ± 12.1 years). Factors affecting the port patency were examined. Age, gender, access, malignancy site, and coagulation parameters were variables. A multivariable Cox regression test was used. Additionally, the successes were compared by univariate Kaplan-Meier survival analysis. Results: Fifty-seven patients underwent port removal because of complications. Complication due to catheter patency time, as number of specific complication per 100 catheter days divided by total patency days shown in parenthesis. Ports were explanted in 29 patients because of thrombosis (0.0054), in nine patients because of infection (0.0017), in eight patients because of catheter malposition (0.0015), in five patients because of bleeding (0.0009), in five patients because of skin necrosis with infection (0.0009) and one patient because of a port reservoir flip-over (0.0002), of a total of 57 patients (0.0107). The patency was similar in the two central veins (P = 0.230). No factor was significant except for the malignancy site (P = 0.002). The malignancy site and gender were significant factors for thrombosis. Port removal was significantly higher in extremities involving two regions and in female patients. Conclusions: Patency was not different between two venous access groups. The malignancy site was the only significant factor for success. Keywords: Central Venous Port; Interventional Radiology; Cancer; Thrombosis; Catheter
- Open Access
- 17 August 2016
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 14 (1)
Percutaneous Management of Cystobiliary Fistulas by Small Catheters
Objectives: This study aims to use mean volume of fluid, which is drained from a liver hydatid cyst with cystobiliary fistula developing after percutaneous treatment, for determining the type of treatment as surgery versus conservative. Patients and Methods: The cohort data was collected retrospectively from 10 out of 90 hydatid cysts in 10 out of 65 patients treated percutaneously with needle and catheterization methods. Groups were defined as surgical and conservative. The mean volumes until the 20th day after detection of the biliary fistula were used. In addition, the mean volumes until the 20th day of 42 catheterization patients without biliary fistula were used as controls for quantitative analysis. Results: All 10 cysts with cystobiliary fistulas were managed with small (8 F) catheters. All patients in the conservative group had < 211 mL/day mean drainage for the 20 days. For the patients that developed cystobiliary fistulas of liver hydatid disease, 30% required surgical treatment. After receiver operating characteristic (ROC) curve analysis, the cut-off value for success of hydatid cyst treatment was 206 mL/day of drained content. Conclusion: To reduce superfluous costs and time, cystobiliary fistula with < 206 mL/day mean drainage until the 20th day may be efficiently treated with percutaneous drainage using small catheters. Keywords: Percutaneous Treatment; Hydatid Cyst; Cystobiliary Fistula; Drainage; Rupture
- 17 August 2016
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 14 (1)
Open AccessPercutaneous Management of Cystobiliary Fistulas by Small Catheters
Objectives: This study aims to use mean volume of fluid, which is drained from a liver hydatid cyst with cystobiliary fistula developing after percutaneous treatment, for determining the type of treatment as surgery versus conservative. Patients and Methods: The cohort data was collected retrospectively from 10 out of 90 hydatid cysts in 10 out of 65 patients treated percutaneously with needle and catheterization methods. Groups were defined as surgical and conservative. The mean volumes until the 20th day after detection of the biliary fistula were used. In addition, the mean volumes until the 20th day of 42 catheterization patients without biliary fistula were used as controls for quantitative analysis. Results: All 10 cysts with cystobiliary fistulas were managed with small (8 F) catheters. All patients in the conservative group had < 211 mL/day mean drainage for the 20 days. For the patients that developed cystobiliary fistulas of liver hydatid disease, 30% required surgical treatment. After receiver operating characteristic (ROC) curve analysis, the cut-off value for success of hydatid cyst treatment was 206 mL/day of drained content. Conclusion: To reduce superfluous costs and time, cystobiliary fistula with < 206 mL/day mean drainage until the 20th day may be efficiently treated with percutaneous drainage using small catheters. Keywords: Percutaneous Treatment; Hydatid Cyst; Cystobiliary Fistula; Drainage; Rupture